Skip to Content


Notice of Prospective Patent License

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


National Aeronautics and Space Administration.


Notice of prospective patent license.


NASA hereby gives notice that CJAB Associates, LLP, of Houston, TX, has applied for a partially exclusive license to practice the inventions described and claimed in U.S. Patent No. 5,153,132, entitled “Three-Dimensional Co-Culture Process;” U.S. Patent No. 5,153,133, entitled “Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor;” U.S. Patent No. 5,155,034, entitled “Three-Dimensional Cell to Tissue Assembly Process;” U.S. Patent No. 5,155,035, entitled “Method for Culturing Mammalian Cells in a Perfused Bioreactor;” U.S. Patent No. 5,308,764, entitled “Multi-Cellular Three Dimensional Living Mammalian Tissue;” U.S. Patent No. 5,496,722, entitled “Method for Producing Non-Neoplastic, 3-Dimensional Mammalian Tissue and Cell Aggregates under Start Printed Page 3619Microgravity Culture Conditions and the Products Produced Thereby;” U.S. Patent No. 5,627,021, entitled “Multi-Cellular, Three-Dimensional Living Mammalian Tissue;” U.S.Patent No. 5,846,807, entitled “Media Compositions for Three-Dimensional Mammalian Tissue Growth Under Microgravity Culture Conditions;” U.S. Patent No. 5,858,783, entitled “Production of Normal Mammalian Organ Culture Using a Medium Containing Mem-Alpha, Leibovitz L-15, Glucose Galactose Fructose;” U.S. Patent No. 5,851,816, entitled “Cultured High-Fidelity Three Dimensional Human Urogenital Tract Carcinomas and Process;” and U.S. Patent No. 6,117,674, entitled “Horizontal Rotating-Wall Vessel Propagation in Vitro Human Tissue Models.” Each of the above U.S. Patents is assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. Written objections to the prospective grant of a license should be sent to the Johnson Space Center.


Responses to this notice must be received by March 19, 2001.

Start Further Info


James Cate, Patent Attorney, NASA Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone (281) 483-1001.

Start Signature

Dated: January 9, 2001.

Edward A. Frankle,

General Counsel.

End Signature End Further Info End Preamble

[FR Doc. 01-1125 Filed 1-12-01; 8:45 am]